BONESUPPORT™ DATA PRESENTED AT EORS HIGHLIGHTS CERAMENT® BONE VOID FILLER’S ABILITY TO ELUTE DRUGS WITH POTENTIAL TO ENHANCE BONE GROWTH
Lund, Sweden, 08.00 CEST, 20 September 2017 – BONESUPPORT an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT platform announces that a pre-clinical study evaluating the in-vivo release kinetics of radio-labelled bone morphogenic protein (rhBMP-2) and zoledronic acid (ZA) from CERAMENT BONE VOID FILLER (BVF) was presented at the European Orthopaedic Research Society (EORS) in Munich on 15th September. The presentation was given by Mr Deepak Raina,